0001209191-22-049156.txt : 20220908 0001209191-22-049156.hdr.sgml : 20220908 20220908161911 ACCESSION NUMBER: 0001209191-22-049156 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220906 FILED AS OF DATE: 20220908 DATE AS OF CHANGE: 20220908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pesquin Gustavo CENTRAL INDEX KEY: 0001944691 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38485 FILM NUMBER: 221234039 MAIL ADDRESS: STREET 1: 4 PARK LANE CITY: MADISON STATE: NJ ZIP: 07940 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001723128 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: BUSINESS PHONE: (908) 947-3120 MAIL ADDRESS: STREET 1: 400 CROSSING BOULEVARD STREET 2: 3RD FLOOR CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Atlas Holdings, Inc. DATE OF NAME CHANGE: 20171117 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-09-06 0 0001723128 Amneal Pharmaceuticals, Inc. AMRX 0001944691 Pesquin Gustavo C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 0 1 0 0 See Remarks Restricted Stock Units 2022-09-06 4 A 0 444444 0.00 A Class A Common Stock 444444 444444 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. The restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date. Title: Executive Vice President, Chief Commercial Officer - Specialty /s/ Jason B. Daly, Attorney-in-Fact 2022-09-08